• 不 限
  • 期刊论文
  • 硕博论文
  • 会议论文
  • 报 纸
  • 英文论文
  2. 您的位置
  3. 首页
  4. 会议论文
  5. Safety and efficacy of a novel abluminal groove-filled biodegradable polymer sirolimus-eluting stent

Safety and efficacy of a novel abluminal groove-filled biodegradable polymer sirolimus-eluting stent

来源 :第十二届中国介入心脏病学大会(CIT2014) | 被引量 : 0次 | 上传用户：xiebf1985
【摘 要】
：
Background TARGET Ⅰ randomized controlled trial demonstrated that the novel abluminal groove-filled biodegradable polymer sirolimus-eluting stent FIREHAWK (MicroPort Medical,Shanghai,China) was non-in
【作 者】
：
Yin Dong Xu Bo Yang Yuejin Zhang Ruiyan Ma Changsheng Li Hui Huo Yong Zhao Yelin Martin B.Leon Gao Runlin 
【机 构】
：
Fu Wai Hospital,National Center for Cardiovascular Diseases,Beijing,China
【出 处】
：
第十二届中国介入心脏病学大会(CIT2014)
【发表日期】
：
2014年3期
下载到本地 , 更方便阅读
下载此文 赞助VIP
声明 : 本文档内容版权归属内容提供方 , 如果您对本文有版权争议 , 可与客服联系进行内容授权或下架
论文部分内容阅读
Background TARGET Ⅰ randomized controlled trial demonstrated that the novel abluminal groove-filled biodegradable polymer sirolimus-eluting stent FIREHAWK (MicroPort Medical,Shanghai,China) was non-inferior to the everolimus-eluting stent with respect to in-stent late loss at 9 months for the treatment of single de novo coronary lesions.The choice of revascularization strategy in multivessel coronary disease (MVD) remains a critical issue in cardiology.The aim of this study was to evaluate the clinical safety and effectiveness of FIREHAWK in patients with MVD from TARGET Clinical Program (TARGET Ⅰ and Ⅱ trials).
其他文献
Post-conditioning benefits acute myocardial infarction in the short-term during primary percutaneous
Background Recently,several studies indicated that ischemic post-conditioning can reduce infarct size and improve heart function.We made the meta-analysis to investigate whether postconditioning prote
会议
Effects of trimetazidine on hibernating myocardium evaluated by 18FDG PET-CT
Background To evaluate the effects of trimetazidine on left ventricular function and thehibemafing myocardium by 18FDG PET-CT in patients with ischemic cardiomyopathy.Methods 60 cases with ischemic ca
会议
Comparison of transradial versus transfemoral method of percutaneous coronary revascularization for
Background The feasibility,efficacy and safety of transradial (TR) versus transfemoral (TF) methods of percutaneous coronary intervention (PCI) for unprotected left main coronary artery (ULMCA) diseas
会议
Impact of disease extent on patients with unprotected left main coronary artery stenosis treated wit
Background Percutaneous coronary intervention (PCI) with drug-eluting stents (DES) implantation has been considered an altemative therapy to cardiac surgery for left main (LM) patients with low to mod
会议
Long-term outcomes of unprotected left main stenting with drug-eluting stent:data derived from a lar
Background Percutaneous coronary intervention (PCI) with drug-eluting stents (DES) implantation has been considered an alternative therapy to cardiac surgery for left main (LM) patients with low to mo
会议
Decreased pharmacodynamic effects from switching high-dose atorvastatin to rosuvastatin in senile Ch
Background Clopidogrel and statin are strongly recommended after percutaneous coronary intervention,and administration of high dose statin can notably improve prognosis in elder patients with high ris
会议
Paclitaxel-coated balloon versus paclitaxel-eluting stent for the treatment of DES in-stent restenos
Background Treatment of drug-eluting stent in-stent restenosis (DES-ISR) is still challenging especially in small coronary arteries.The intention of this sub-group analysis is to compare the safety an
会议
Paclitaxel-coated balloon versus paclitaxel-eluting stent for the treatment of diffuse DES in-stent
Background Treatment of drug-eluting stent in-stent restenosis (DES-ISR) is still challenging especially in diffuse lesions.The intention of this subgroup analysis is to compare the safety and effecti
会议
Clinical impact of prolonged dual antiplatelet therapy for true bifurcation coronary artery lesion t
Background Twelve-month dual antiplatelet therapy (DAT) with aspirin and clopidogrel after drug-eluting stent (DES) implantation is routinely recommended.It is unclear if prolonged (＞ 12 months) DAT i
会议
Efficacy and safety of clopidogrel added proton pump inhibitors vs.clopidogrel in the treatment of c
Background The combination of clopidogrel added proton pump inhibitors after a percutaneous coronary intervention has been used in clincal therapy,but whether it is safe and effective should be furthe
会议